Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade
This article was originally published in PharmAsia News
SEOUL - South Korean President Lee Myung-bak named "17 new growth engines" at a science and technology council meeting at his office in Seoul Jan. 13. Expected to spearhead the country's economic growth for the next 10 years, of those 17 economic growth engines, the Korean government targeted biologics, medical devices and global health care among the national priorities
You may also be interested in...
South Korea’s Ministry of Health and Welfare is launching its second ‘Global Pharma Industry Development Fund’ worth KRW135 billion ($124 million) to help small and mid-sized local firms with cooperative technology development, deals with foreign venture firms, sales networks and production facilities in foreign countries, and global clinical trials.
The proposal would expand KFDA’s regulatory oversight powers, despite pushback from the health ministry.
Whoever wins the Dec. 19 presidential election in Korea is expected to consider another round of drug prices cuts as a way to pay for expanded health care coverage.